Investigational drug · Phase 3
BR005-036C
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Migraine, With or Without Aura.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "BR005-036C"
First trial start
2026
Sep 30, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "BR005-036C", any sponsor or status.
Conditions studied
As listed on its trial records.
- Migraine, With or Without Aura
Approved drugs for the same conditions: Migraine · Neurology
Largest trials
Live from ClinicalTrials.gov: studies naming "BR005-036C" as an intervention, largest first.
- Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in AdultsPivotal-lookingRecruiting
Brise Pharmaceuticals Co., Ltd.Industry
NCT07792681 · 2,079 participants (planned) · Start Sep 30, 2026 · Primary completion Jun 30, 2028
Drug: BR005-036C; BR005-036C and 1 more · For: Migraine, With or Without Aura
Sites: Shanxi, China; Inner Mongolia, China; Beijing, China · 81 sites in all
- Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in AdultsPivotal-lookingNot yet recruiting
Brise Pharmaceuticals Co., Ltd.Industry
NCT07835152 · 1,000 participants (planned) · Start Nov 20, 2026 · Primary completion Mar 31, 2029
Drug: BR005-036C · For: Migraine, With or Without Aura
Sites: Shanxi, China; Inner Mongolia, China; Beijing, China · 79 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.